MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
About Us

Global Audience

With an audience over 190,000 visitors per month, Pharmalicensing is a leading destination for decision makers within the pharmaceutical and biotech licensing community. Covering the full spectrum of the industry, from large pharmaceutical companies to small biotech companies along with academic institutions, Pharmalicensing users offer a true reflection of the industry, its trends and interests.

Over half of the Pharmalicensing audience is made up of the industry's most senior decision makers, CEO's, Chairmen, VP's, Licensing and Business Development Managers, ensuring the right people are looking at your opportunities.

Maximising your chance of finding partners, the Pharmalicensing audience is truly global. Covering USA (40%), Europe (28%), Asia and Australasia (24%) and the rest of the world (8%), our services introduce your company and opportunities to new arenas and contacts.

Geo map 2008

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us